6minutes 
 News

Professor Ian Frazer behind new COVID-19 drug

Clinical trials starting this week will test the immunotherapy drug IC14 in coronavirus patients in 10-15 hospitals across the US
Australian Associated Press
0
16 April 2021
Save
Professor Ian Frazer.
Professor Ian Frazer.

A drug described as a potential new immunotherapy for COVID-19 will enter a clinical trial in the US led by former Australian of the Year Professor Ian Frazer.

Developed by Brisbane and Seattle-based company, Implicit Bioscience, the drug IC14 will this week be tested in COVID-19 patients in 10-15 hospitals across America.

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Content that breaches the privacy of other individuals
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .